CSIG-33. BETA 1 INTEGRIN INHIBITION IN HIGH-GRADE MENINGIOMA

High-grade meningiomas (HGM, World Health Organization classification grade II and III) have high relapse rates and poor clinical outcomes despite surgery and radiation treatments. Developing novel therapeutic strategies requires identification of molecules that drive progression of HGM. Beta 1 inte...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Nigim, Fares, Gurtner, Alessandra, Brastianos, Priscilla, Cahill, Daniel, Rabkin, Samuel D, Martuza, Robert L, Carbonell, Shawn, Wakimoto, Hiroaki
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693097/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.227
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars